Condition
Absorption; Disorder, Protein
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 4 (1)
Trial Status
Unknown2
Completed2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04141826Not ApplicableCompleted
Absorption of Peptides, Fluid, and Electrolytes in Patients With an Ileostomy
NCT04615858Not ApplicableUnknownPrimary
Genepro Generation 3 Protein Bioavailability Compared to Whey Protein
NCT04305535Not ApplicableUnknown
Impact of an Oligomeric Diet in Intestinal Absorption and Inflammatory Markers in Patients With Crohn Disease
NCT02919657Phase 4Completed
Absorption Comparison on Equivalency Value of Genepro Gen2
Showing all 4 trials